These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21738238)

  • 1. Rescue of melanocortin 4 receptor (MC4R) nonsense mutations by aminoglycoside-mediated read-through.
    Brumm H; Mühlhaus J; Bolze F; Scherag S; Hinney A; Hebebrand J; Wiegand S; Klingenspor M; Grüters A; Krude H; Biebermann H
    Obesity (Silver Spring); 2012 May; 20(5):1074-81. PubMed ID: 21738238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the melanocortin-4-receptor nonsense mutation W16X in vitro and in vivo.
    Bolze F; Rink N; Brumm H; Kühn R; Mocek S; Schwarz AE; Kless C; Biebermann H; Wurst W; Rozman J; Klingenspor M
    Pharmacogenomics J; 2013 Feb; 13(1):80-93. PubMed ID: 21969101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Pharmacological Rescue of Melanocortin-4 Receptor Nonsense Mutations by Aminoglycoside.
    Höpfner F; Paisdzior S; Reininghaus N; Sohail I; Scheerer P; Annibale P; Biebermann H; Kühnen P
    Life (Basel); 2022 Nov; 12(11):. PubMed ID: 36362948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations.
    Nagel-Wolfrum K; Möller F; Penner I; Wolfrum U
    Vis Neurosci; 2014 Sep; 31(4-5):309-16. PubMed ID: 24912600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in melanocortin-4 receptor and human obesity.
    Tao YX
    Prog Mol Biol Transl Sci; 2009; 88():173-204. PubMed ID: 20374728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglycosides, but not PTC124 (Ataluren), rescue nonsense mutations in the leptin receptor and in luciferase reporter genes.
    Bolze F; Mocek S; Zimmermann A; Klingenspor M
    Sci Rep; 2017 Apr; 7(1):1020. PubMed ID: 28432296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel non-synonymous mutation in the melanocortin-4 receptor gene (MC4R) in a 2-year-old Austrian girl with extreme obesity.
    Rettenbacher E; Tarnow P; Brumm H; Prayer D; Wermter AK; Hebebrand J; Biebermann H; Hinney A; Widhalm K
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):7-12. PubMed ID: 17286227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional characterization of three novel human melanocortin-4 receptor gene variants in an obese Chinese population.
    Rong R; Tao YX; Cheung BM; Xu A; Cheung GC; Lam KS
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):198-205. PubMed ID: 16886960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy.
    Howard MT; Shirts BH; Petros LM; Flanigan KM; Gesteland RF; Atkins JF
    Ann Neurol; 2000 Aug; 48(2):164-9. PubMed ID: 10939566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of a methylmalonyl-CoA mutase stopcodon mutation.
    Buck NE; Wood LR; Hamilton NJ; Bennett MJ; Peters HL
    Biochem Biophys Res Commun; 2012 Nov; 427(4):753-7. PubMed ID: 23041189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro.
    Popescu AC; Sidorova E; Zhang G; Eubanks JH
    J Neurosci Res; 2010 Aug; 88(11):2316-24. PubMed ID: 20623622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Readthrough of dystrophin stop codon mutations induced by aminoglycosides.
    Howard MT; Anderson CB; Fass U; Khatri S; Gesteland RF; Atkins JF; Flanigan KM
    Ann Neurol; 2004 Mar; 55(3):422-6. PubMed ID: 14991821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocortin-4 receptor in energy homeostasis and obesity pathogenesis.
    Hinney A; Volckmar AL; Knoll N
    Prog Mol Biol Transl Sci; 2013; 114():147-91. PubMed ID: 23317785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons.
    Zilberberg A; Lahav L; Rosin-Arbesfeld R
    Gut; 2010 Apr; 59(4):496-507. PubMed ID: 19951906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological chaperones increase the cell-surface expression of intracellularly retained mutants of the melanocortin 4 receptor with unique rescuing efficacy profiles.
    Ward NA; Hirst S; Williams J; Findlay JB
    Biochem Soc Trans; 2012 Aug; 40(4):717-20. PubMed ID: 22817722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.
    Kerem E; Hirawat S; Armoni S; Yaakov Y; Shoseyov D; Cohen M; Nissim-Rafinia M; Blau H; Rivlin J; Aviram M; Elfring GL; Northcutt VJ; Miller LL; Kerem B; Wilschanski M
    Lancet; 2008 Aug; 372(9640):719-27. PubMed ID: 18722008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of third intracellular loop of the melanocortin 4 receptor in the regulation of constitutive activity.
    Kim DH; Shin SW; Baik JH
    Biochem Biophys Res Commun; 2008 Jan; 365(3):439-45. PubMed ID: 17986382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity.
    Tao YX
    Mol Cell Endocrinol; 2005 Jul; 239(1-2):1-14. PubMed ID: 15975705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation Thr162Arg of the melanocortin 4 receptor gene in a Spanish children and adolescent population.
    Ochoa MC; Azcona C; Biebermann H; Brumm H; Razquin C; Wermter AK; Martínez JA; Hebebrand J; Hinney A; Moreno-Aliaga MJ; Marti A; Patiño A; Chueca M; Oyarzabal M; Pelach R;
    Clin Endocrinol (Oxf); 2007 May; 66(5):652-8. PubMed ID: 17492953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response.
    Roubert P; Dubern B; Plas P; Lubrano-Berthelier C; Alihi R; Auger F; Deoliveira DB; Dong JZ; Basdevant A; Thurieau C; Clément K
    J Endocrinol; 2010 Nov; 207(2):177-83. PubMed ID: 20696697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.